A stereospecific myo-inositol D-chiro-inositol transporter in HepG2 liver cells - Identification with D-chiro-[3-H-3]inositol

被引:35
作者
Ostlund, RE
Seemayer, R
Gupta, S
Kimmel, R
Ostlund, EL
Sherman, WR
机构
[1] WASHINGTON UNIV,SCH MED,DIV METAB,ST LOUIS,MO 63110
[2] WASHINGTON UNIV,DEPT PSYCHIAT,ST LOUIS,MO 63110
[3] GENENCOR INT INC,S SAN FRANCISCO,CA 94080
[4] AMER RADIOLABELED CHEM INC,ST LOUIS,MO 63146
关键词
D O I
10.1074/jbc.271.17.10073
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
D-chiro-Inositol is an epimer of myo-inositol that is found in certain mammalian glycosylphosphatidylinositol protein anchors and inositol phosphoglycans possessing insulin-like bioactivity. In order to generate a probe for metabolic studies, D-chiro-[3-H-3]inositol was synthesized by selective reduction of D-chiro-3-inosose at pH 6.5 with sodium borotritide. D-chiro-[3-H-3]Inositol was taken up by HepG2 human liver cells through a saturable and stereospecific pathway in which D-chiro-inositol and myo-inositol competed equally but L-chiro-inositol was not recognized. D-Glucose, but not L-glucose, competed for D-chiro-[3-H-3]inositol uptake over glucose concentrations of 4-28 mM. Maximum transport capacity was 717 pmol/mg cell protein/3 h with a K-m value of 348 mu M. Uptake was reduced by 76% when sodium was eliminated from the medium and by 94% when the experiment was performed at 0 degrees C. The new myo/D-chiro-inositol transporter is distinct from the sodium-myo-inositol co-transporter found in many tissues and accounts for all of the saturable D-chiro-inositol uptake and for a portion of the saturable low affinity myo-inositol uptake in HepG2 cells. It may allow D-chiro-inositol to be used by cells in the presence of a relatively large amount of competing myo-inositol.
引用
收藏
页码:10073 / 10078
页数:6
相关论文
共 50 条
  • [41] Effects of dietary myo-inositol, D-chiro-inositol and L-chiro-inositol on hepatic lipids with reference to the hepatic myo-inositol status in rats fed on 1,1,1-trichloro-2,2-bis (p-chlorophenyl) ethane
    Okazaki, Yukako
    Setoguchi, Tomoyasu
    Katayama, Tetsuyuki
    BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY, 2006, 70 (11) : 2766 - 2770
  • [42] Role of Myo-inositol and D-Chiro-Inositol in Improvement of Endocrine and Clinical Parameters in Teenage Girls affected by PCOS: A Prospective Cohort Study
    Khan, Rubeena Badar
    Sarosh, Muntiha
    Anwer, Shehnaz
    PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2022, 16 (01): : 21 - 24
  • [43] Myo-inositol and D-chiro-inositol oral supplementation ameliorate cardiac dysfunction and remodeling in a mouse model of diet-induced obesity
    L'Abbate, Serena
    Nicolini, Giuseppina
    Forini, Francesca
    Marchetti, Sabrina
    Di Lascio, Nicole
    Faita, Francesco
    Kusmic, Claudia
    PHARMACOLOGICAL RESEARCH, 2020, 159
  • [44] Metabolomic change due to combined treatment with myo-inositol, D-chiro-inositol and glucomannan in polycystic ovarian syndrome patients: a pilot study
    Jacopo Troisi
    Claudia Cinque
    Luigi Giugliano
    Steven Symes
    Sean Richards
    David Adair
    Pierpaolo Cavallo
    Laura Sarno
    Giovanni Scala
    Maria Caiazza
    Maurizio Guida
    Journal of Ovarian Research, 12
  • [45] Results from the International Consensus Conference on Myo-inositol and D-chiro-inositol in Obstetrics and Gynecology: the link between metabolic syndrome and PCOS
    Facchinetti, Fabio
    Bizzarri, Mariano
    Benvenga, Salvatore
    D'Anna, Rosario
    Lanzone, Antonio
    Soulage, Christophe
    Di Renzo, Gian Carlo
    Hod, Moshe
    Cavalli, Pietro
    Chiu, Tony T.
    Kamenov, Zdravko A.
    Bevilacqua, Arturo
    Carlomagno, Gianfranco
    Gerli, Sandro
    Oliva, Mario Montanino
    Devroey, Paul
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2015, 195 : 72 - 76
  • [46] The 40:1 myo-inositol/D-chiro-inositol plasma ratio is able to restore ovulation in PCOS patients: comparison with other ratios
    Nordio, M.
    Basciani, S.
    Camajani, E.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 (12) : 5512 - 5521
  • [47] Combining treatment with myo-inositol and D-chiro-inositol (40:1) is effective in restoring ovary function and metabolic balance in PCOS patients
    Monastra, Giovanni
    Unfer, Vittorio
    Harrath, Abdel Halim
    Bizzarri, Mariano
    GYNECOLOGICAL ENDOCRINOLOGY, 2017, 33 (01) : 1 - 9
  • [48] Metabolomic change due to combined treatment with myo-inositol, D-chiro-inositol and glucomannan in polycystic ovarian syndrome patients: a pilot study
    Troisi, Jacopo
    Cinque, Claudia
    Giugliano, Luigi
    Symes, Steven
    Richards, Sean
    Adair, David
    Cavallo, Pierpaolo
    Sarno, Laura
    Scala, Giovanni
    Caiazza, Maria
    Guida, Maurizio
    JOURNAL OF OVARIAN RESEARCH, 2019, 12 (1)
  • [49] D-chiro-inositol glycan stimulates insulin secretion in pancreatic β cells
    Lazarenko, Roman
    Geisler, Jessica
    Bayliss, Douglas
    Larner, Joseph
    Li, Chien
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2014, 387 (1-2) : 1 - 7
  • [50] Strategy to improve the female fertility in the general gynecologist's office: use of a nutritional supplement based on myo-inositol/D-chiro-inositol and antioxidants
    Mendoza, Nicolas
    Losa, Fernando
    Palacios, Santiago
    GYNECOLOGICAL ENDOCRINOLOGY, 2022, 38 (04) : 275 - 278